Detection method of fingerprint spectrum of chemical components in pediatric fever abatement preparation, establishment method of fingerprint spectrum and application of fingerprint spectrum of chemical components in pediatric fever abatement preparation

High performance liquid chromatography detects the chemical components in the erectin preparation and establishes a fingerprint map, which solves the problem of failure to effectively control the quality of the preparation in the existing technology, achieves more scientific and perfect quality control, and ensures that The safety and effectiveness of the drug.

CN119086737APending Publication Date: 2024-12-06CHENGDU HUASUN GRP INC LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410845284.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-27
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art has failed to effectively control the basic components of the erectile antipyretin preparation, and lacks quality control methods for the chemical components of the preparation, especially the use of liquid chromatography peaks to display the chemical components of the substance, which affects the quality and safety of the drug.

Method used

High performance liquid chromatography is used to detect the chemical components in the erectile antipyretin preparation, and fingerprint patterns are established by selecting appropriate chromatographic columns, mobile phase gradients and detection wavelengths to ensure the accuracy and resolution of the detection results.

Benefits of technology

It realizes efficient separation and quality control of chemical components of the erectile antipyretic preparation, improves the safety and effectiveness of drugs, and ensures the quality and safety of clinical drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086737A_ABST
    Figure CN119086737A_ABST
Patent Text Reader

Abstract

The invention provides a detection method of a fingerprint spectrum of chemical components in a pediatric fever abatement preparation, an establishment method of the fingerprint spectrum and application of the fingerprint spectrum. According to the method, the chemical components in the pediatric antipyretic preparation are detected by adopting the high performance liquid chromatography, the defects of the quality control technology of the pediatric antipyretic preparation in the prior art are overcome, and the chemical components in the pediatric antipyretic preparation can be effectively separated, so that the quality control of the pediatric antipyretic preparation is more perfect and scientific; the purpose of controlling the quality of the pediatric antipyretic drug preparation so as to monitor the safety production of the drug is achieved, and the safety and effectiveness of clinical medication are ensured. Meanwhile, by controlling the detection wavelength, screening the proper mobile phase system and determining the proper mobile phase gradient, the accuracy of the positioning result of the chemical components in the fingerprint spectrum is improved, meanwhile, the purpose of good separation degree is achieved, and the stability is good.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of drug analysis, and specifically relates to a method for detecting a fingerprint spectrum of chemical components in an Ergan Tuirening preparation, a method for establishing a fingerprint spectrum and an application thereof. Background Art

[0002] Ergan Tuirening preparation is a traditional Chinese medicine preparation made from 8 medicinal materials including Artemisia annua, Forsythia suspensa, Platycodon grandiflorum, Isatis indigotica, Chrysanthemum, Bitter almond, Mint, and Licorice. After years of clinical observation, it has been found that it can stably reduce fever in children with acute upper respiratory tract infection, and can significantly improve symptoms such as cough, shortness of breath, pharyngeal congestion, and lung signs. It is mainly used to treat children with exogenous wind-heat, internal fire depression, fever, headache, cough, sore throat and other diseases. It has the characteristics of definite efficacy, rapid effect, low recurrence rate, and no toxic side effects.

[0003] As we all know, the quality of drugs is the premise to ensure the safety and effectiveness of clinical drugs. Ergan Tuirening preparations contain a large number of saponins, phenolic acids, and phenylpropanoids, which have a great effect on clinical efficacy. At present, the quality control method for Ergan Tuirening preparations recorded in the pharmacopoeia only controls the ammonium glycyrrhizinate component, and does not study and control the material basis components in Ergan Tuirening preparations. In addition, the current existing technology does not use liquid chromatography peaks to display the chemical composition of the substance for Ergan Tuirening preparations. Summary of the invention

[0004] In view of this, the object of the present invention is to provide a method for detecting the fingerprint spectrum of the chemical components in the Ergan Tuirening preparation, a method for establishing the fingerprint spectrum and its application, which method has accurate results, high separation degree and good stability.

[0005] To achieve this object, the present invention adopts the following technical solutions:

[0006] In a first aspect, the present invention provides a method for detecting the fingerprint of chemical components in the Ergan Tuirening preparation, comprising:

[0007] The Ergan Tuirening preparation test solution is subjected to high performance liquid chromatography analysis to obtain a chromatogram of the test solution;

[0008] The chromatographic conditions of the high performance liquid chromatography are:

[0009] The chromatographic column is filled with octadecylsilane bonded silica gel;

[0010] The flow rate of the mobile phase was 0.8-1.5 mL / min; the mobile phase was gradient elution;

[0011] Mobile phase A was acetonitrile; mobile phase B was 0.1 vol% phosphoric acid solution;

[0012] The column temperature was 30-40°C; the injection volume was 10-20 μL; and the detection wavelength was 201-210 nm.

[0013] Preferably, in terms of volume percentage, the procedure of the gradient elution is:

[0014] 0-5min, mobile phase A is 12%;

[0015] 5-14 min, mobile phase A is 12%-20%;

[0016] 14-21 min, mobile phase A is 20%-22%;

[0017] 21-29 min, mobile phase A is 22%-23%;

[0018] 29-39 min, mobile phase A is 23%-28%; 39-48 min, mobile phase A is 28%-42%; 48-68 min, mobile phase A is 42%-60%; 68-70 min, mobile phase A is 60%-12%; 70-72 min, mobile phase A is 12%;

[0019] or

[0020] 0-15min, mobile phase A is 20%-28%; 15-23min, mobile phase A is 28%-32%; 23-36min, mobile phase A is 32%; 36-38min, mobile phase A is 32%-34%; 38-40min, mobile phase A is 34%-35%; 40-43min, mobile phase A is 35%-36%; 43-48min, mobile phase A is 36%-37%; 48-50min, mobile phase A is 37%-39%; 50-60min, mobile phase A is 39%-50%; 60-70min, mobile phase A is 50%-80%; 70-71min, mobile phase A is 80%-20%; 71-75min, mobile phase A is 20%;

[0021] or

[0022] 0-5min, mobile phase A is 12%;

[0023] 5-10min, mobile phase A is 12%-18%; 10-21min, mobile phase A is 18%-22%; 21-27min, mobile phase A is 22%-23%; 27-40min, mobile phase A is 23%-25%; 40-45min, mobile phase A is 25%-40%; 45-46min, mobile phase A is 40%; 46-70min, mobile phase A is 40%-54%; 70-73min, mobile phase A is 54%-12%; 73-75min, mobile phase A is 12%;

[0024] or

[0025] 0-5min, mobile phase A is 12%;

[0026] 5-10 min, mobile phase A is 12%-18%; 10-36 min, mobile phase A is 18%-23%; 36-47 min, mobile phase A is 23%-26%; 47-53 min, mobile phase A is 26%-40%; 53-55 min, mobile phase A is 40%; 55-70 min, mobile phase A is 40%-54%; 70-73 min, mobile phase A is 54%;

[0027] 73-75min, mobile phase A is 54%-12%;

[0028] 75-80 min, mobile phase A is 12%;

[0029] or

[0030] 0-5min, mobile phase A is 12%;

[0031] 5-10 min, mobile phase A is 12%-18%;

[0032] 10-45 min, mobile phase A is 18%-23%;

[0033] 45-56 min, mobile phase A is 23%-26%;

[0034] 56-65min, mobile phase A is 26%-40%;

[0035] 65-66 min, mobile phase A is 40%;

[0036] 66-78 min, mobile phase A is 40%-60%;

[0037] 78-85 min, mobile phase A is 60%-12%;

[0038] or

[0039] 0-5min, mobile phase A is 12%;

[0040] 5-10 min, mobile phase A is 12%-20%;

[0041] 10-27 min, mobile phase A is 20%-23%;

[0042] 27-40 min, mobile phase A is 23%-26%;

[0043] 40-49 min, mobile phase A is 26%-40%;

[0044] 49-70 min, mobile phase A is 40%-60%;

[0045] 70-71 min, mobile phase A is 60%;

[0046] 71-73 min, mobile phase A is 60%-12%;

[0047] 73~75min, mobile phase A is 12%.

[0048] Preferably, the chromatographic column is a GL Inertsil ODS-3 chromatographic column; the flow rate is 1.0 mL / min; the column temperature is 30° C.; the injection volume is 10 μL; and the detection wavelength is 201 nm.

[0049] Preferably, the Ergan Tuirening preparation test solution is obtained by diluting the Ergan Tuirening preparation.

[0050] Preferably, the dilution solvent is water; the dilution multiple is 5 to 12.5 times.

[0051] Preferably, the detection method further comprises preparing a mixed reference substance:

[0052] Amygdalin, forsythiaside A, scopoletin, forsythin, luteolin and ammonium glycyrrhizinate were mixed with 100 vol% methanol to prepare a mixed reference substance;

[0053] The mixed reference substance is subjected to high performance liquid chromatography analysis to obtain a chromatogram of the mixed reference substance.

[0054] Preferably, the mixed reference substance contains 0.2-0.3 mg / mL of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate respectively;

[0055] According to the retention time of the mixed reference substance in the chromatogram and the retention time of the components corresponding to amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the test solution in the chromatogram of the test solution, the retention time of the active ingredients of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the Ergan Tuirening preparation is obtained.

[0056] Preferably, the retention time of peak 3 corresponding to the amygdalin is 12.390 min; the retention time of peak 8 corresponding to the forsythiaside A is 20.513 min; the retention time of peak 10 corresponding to the scopoletin is 23.109 min; the retention time of peak 15 corresponding to the forsythiaside is 39.403 min; the retention time of peak 17 corresponding to the luteolin is 47.316 min; the retention time of peak 19 corresponding to the ammonium glycyrrhizinate is 54.570 min.

[0057] Preferably, the Ergan Tuirening preparation is made with Artemisia annua, Radix Isatidis, Chrysanthemum, Bitter Almond, Platycodon, Forsythia suspensa, Mint and Licorice as active ingredients.

[0058] Preferably, the dosage form of the Ergan Tuirening preparation is granules, tablets, capsules, powders, pills, suspensions or oral liquid preparations.

[0059] In a second aspect, the present invention provides a method for establishing a fingerprint of chemical components in an Ergan Tuirening preparation, which adopts the above-mentioned method for detecting the fingerprint of chemical components in an Ergan Tuirening preparation to obtain a fingerprint of chemical components in an Ergan Tuirening preparation.

[0060] In a third aspect, the present invention provides an application of a fingerprint obtained by the above detection method or a fingerprint of chemical components in the Ergan Tuirening preparation obtained according to the above established method in the quality control of the Ergan Tuirening preparation.

[0061] Compared with the prior art, the present invention has the following beneficial effects:

[0062] The present invention adopts high performance liquid chromatography to detect the chemical components in the Ergan Tuirening preparation, overcomes the shortcomings of the prior art in the quality control technology of the Ergan Tuirening preparation, can effectively separate the chemical components in the Ergan Tuirening preparation, make its quality control more perfect and scientific, achieve the purpose of controlling the quality of the Ergan Tuirening preparation and then monitoring the safe production of drugs, and ensure the safety and effectiveness of clinical medication. At the same time, the present invention improves the accuracy of the chemical component positioning results in the fingerprint spectrum by controlling the detection wavelength, screening a suitable mobile phase system, and determining a suitable mobile phase gradient, while achieving good separation and good stability. BRIEF DESCRIPTION OF THE DRAWINGS

[0063] Figure 1 It is a comparison diagram of fingerprint spectra obtained under different dilution solvents;

[0064] Figure 2 It is a comparison diagram of fingerprints obtained at different dilution multiples;

[0065] Figure 3 It is a comparison diagram of fingerprint spectra obtained under different detection wavelengths;

[0066] Figure 4 Comparison of fingerprints obtained for different mobile phase systems;

[0067] Figure 5 This is a comparison of the fingerprints obtained by the M1 and M2 methods;

[0068] Figure 6 It is a comparison diagram of the fingerprints obtained by M3, M4, M5 and M6 methods;

[0069] Figure 7 It is a comparison diagram of fingerprints obtained under different chromatographic columns;

[0070] Figure 8 The spectra of single medicinal materials of water, Artemisia annua, Forsythia suspensa, Platycodon grandiflorum, Radix Isatidis, Chrysanthemum, Bitter almond, Mint, Licorice and Ergan Tuirening preparation;

[0071] Fig. 9 The spectra are those of the reference solution and the Ergan Tuirening preparation;

[0072] Fig.10 The spectra of the reference solution and Ergan Tuirening preparation;

[0073] Fig.11 This is the fingerprint of Ergan Tuirening preparation;

[0074] Fig.12 It is the specific fingerprint of Ergan Tuirening preparation;

[0075] Fig.13 This is a comparison chart of the fingerprints of Ergan Tuirening preparation obtained under precision testing;

[0076] Fig.14 This is a comparison diagram of the fingerprints of Ergan Tuirening preparation obtained under repeatability testing;

[0077] Fig.15 This is a comparison diagram of the fingerprints of the Ergan Tuirening preparation obtained under stability testing;

[0078] Fig.16 This is a comparison chart of the fingerprint spectra obtained from 10 batches of Ergan Tuirening preparation samples. DETAILED DESCRIPTION

[0079] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0080] The present invention provides a method for detecting the fingerprint of chemical components in the Ergan Tuirening preparation, comprising:

[0081] S1) diluting the Ergan Tuirening preparation, filtering through a microporous filter membrane, and taking the filtrate to obtain a test solution;

[0082] S2) preparing a mixed reference substance: the reference substance in the mixed reference substance includes amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate;

[0083] S3) using high performance liquid chromatography, under the same detection conditions, respectively obtain the chromatograms of the chemical components in the test solution in step S1 and the mixed reference substance in step S2, and the specific detection conditions are as follows:

[0084] The chromatographic column is filled with octadecylsilane bonded silica gel;

[0085] The flow rate of the mobile phase was 0.8-1.5 mL / min; the mobile phase was gradient elution;

[0086] Mobile phase A was acetonitrile; mobile phase B was 0.1 vol% phosphoric acid solution;

[0087] The column temperature is 30-40°C, preferably 30°C; the injection volume is 10-20 μL, preferably 10 μL; the detection wavelength is 201-210 nm;

[0088] S4) according to the retention time of the mixed reference substance in the chromatogram and the retention time of the components corresponding to amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the test solution in the chromatogram of the test solution, and based on the detection conditions in step S3), the retention time of the active ingredients of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the Ergan Tuirening preparation is obtained.

[0089] In the present invention, the Ergan Tuirening preparation is prepared with Artemisia annua, Radix Isatidis, chrysanthemum, bitter almond, Platycodon grandiflorum, Fructus Forsythiae, mint and licorice as active ingredient raw materials. Since the Ergan Tuirening preparation mainly contains water-soluble or relatively polar components, experiments are conducted on the dilution solvent and dilution multiple in the Ergan Tuirening preparation. It is found that the chromatogram peak display integrity and peak separation of the Ergan Tuirening preparation prepared in different dilution solvents (water, methanol, 50 vol% methanol, 20 vol% methanol, ethanol, 50 vol% ethanol, 20 vol% ethanol) are basically consistent, with no obvious difference, such as Figure 1 Therefore, different dilution solvents have no effect on the determination results of the fingerprint spectrum, so low-cost, non-toxic water is preferably selected as the dilution solvent.

[0090] In addition, the present invention found in the experiment that when the Ergan Tuirening preparation was diluted 5 to 12.5 times, the chromatographic peaks of most of the material components could be better characterized as a whole. When diluted 25 times, the chromatographic peak absorption was small, and the characterization of the overall material group was poor, such as Figure 2 As shown. In summary, considering that the greater the dilution factor, the lower the sample concentration, the less impurity adsorption on the chromatographic column, which helps to extend the service life of the chromatographic column. In summary, it is preferred to determine that the dilution factor for the preparation of Ergan Tuirening preparation is 12.5 times.

[0091] In the present invention, the microporous filter membrane can be a common commercial product. The pore size of the microporous filter membrane in the present invention is preferably 0.4 to 0.6 μm, more preferably 0.45 μm.

[0092] The method for preparing the test solution adopted in the present invention has a simple sample preparation method, and the solvent used is preferably an aqueous solution, which is non-toxic and inexpensive.

[0093] In the present invention, the dosage form of the Ergan Tuirening preparation can be prepared into dosage forms well known to those skilled in the art, specifically selected from granules, tablets, capsules, powders, pills, suspensions or oral liquid preparations.

[0094] Furthermore, in the present invention, the mixed reference substance is obtained by mixing the reference substances (amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizate) with 100 vol% methanol, and the mixed reference substance contains 0.2-0.3 mg / L of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizate, respectively, preferably 0.2-0.25 mg / L, and more preferably 0.2 mg / L.

[0095] Furthermore, amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate were taken respectively, and 100 vol% methanol was added to prepare a mixed reference substance; the mixed reference substance contained 0.2-0.3 mg / mL amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate respectively.

[0096] The present invention performs high performance liquid chromatography analysis on the mixed reference substance to obtain a chromatogram of the mixed reference substance.

[0097] At the same time, according to the retention time of the mixed reference substance in the chromatogram and the retention time of the components corresponding to amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the test solution in the chromatogram of the test solution, and based on the detection conditions in step S3), the retention times of the active ingredients of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the Ergan Tuirening preparation are obtained.

[0098] Furthermore, in the present invention, the detection wavelength of the high performance liquid chromatography was screened, and it was found that the test solution of the Ergan Tuirening preparation had a high ultraviolet absorption response at low wavelengths, and displayed more abundant chromatographic peaks (substance components); among them, the number of chromatographic peaks and the response in the test solution spectrum at 201 to 210 nm were significantly superior to those at other wavelengths, such as Figure 3 Therefore, 201-210 nm is selected as the detection wavelength, and 201 nm is more preferred.

[0099] Furthermore, in the present invention, the mobile phase systems (acetonitrile-0.1 vol% phosphoric acid, acetonitrile-0.2 vol% phosphoric acid, acetonitrile-0.1 vol% formic acid) of high performance liquid chromatography were screened, and different mobile phase systems were compared based on the peak display integrity, retention strength, and stability of the spectrum baseline of the fingerprint of the test liquid. Figure 4 As shown. It was found that the baseline of the acetonitrile-phosphoric acid system was more stable than that of the acetonitrile-formic acid system; according to the overall determination of the chromatogram of the fingerprint, the number and peak shape of the fingerprint chromatogram with acetonitrile-0.1% phosphoric acid as the mobile phase system were better than those of the acetonitrile-0.2vol% phosphoric acid mobile phase system, and no baseline drift occurred. Therefore, it is preferred to determine that the mobile phase system of the fingerprint of the test liquid is acetonitrile-0.1vol% phosphoric acid.

[0100] Further, in the present invention, experiments were conducted on the elution gradient program of the mobile phase of the high performance liquid chromatography, and the mobile phase gradient is shown in Table 1. The results are shown in Table 1. Figure 5 and Figure 6 shown.

[0101] Table 1

[0102]

[0103]

[0104] from Figure 5 and Figure 6 It can be seen that the chromatographic peak shape and separation degree of the test solution obtained by method M6 are better, and the elution time is shorter, which is conducive to rapid detection.

[0105] Furthermore, since different chromatographic columns have great differences in the retention capacity of components, in the present invention, experiments were conducted on the chromatographic columns of high performance liquid chromatography, as shown in Table 2. The results are as follows: Figure 7 shown.

[0106] Table 2

[0107] Serial number Chromatographic columns 28# Specifications and models: Agilent ZORBAX SB-C18 (250mm*4.6mm, 5μm) 33# Specifications and models: Waters Sunfire C18 (250mm*4.6mm, 5μm) 34# Specifications and models: Waters XSelect HSS T3 (250mm*4.6mm, 5μm) 36# Specifications and models: Waters Symmetry slield RP 18 (250mm*4.6mm, 5μm) 40# Specifications and models: Ultimate LP-C18 (250mm*4.6mm, 5μm) 54# Specifications and models: GL Inertisil ODS-3 (250mm*4.6mm, 5μm)

[0108] The results show that the GL InertsilODS-3 chromatographic column has a more stable baseline than the other chromatographic columns, and has better peak separation at 15 to 25 minutes; therefore, from the perspective of the overall separation effect and retention time of the present invention, it is better to select the GL InertsilODS-3 chromatographic column for detection; the GL InertsilODS-3 chromatographic column can be a general commercially available product.

[0109] Example

[0110] In summary, the method for detecting the fingerprint of the chemical components in the Ergan Tuirening preparation comprises the following steps:

[0111] S1) Take 2 mL of Ergan Tuirening preparation, add water to make up to 25 mL, filter through a 0.45 μm microporous filter membrane, and take the filtrate to obtain the test solution;

[0112] S2) preparing a mixed reference substance: taking amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate respectively, adding 100 vol% methanol to prepare a mixed reference substance; the mixed reference substance contains 0.2 mg / mL amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate respectively;

[0113] S3) using high performance liquid chromatography to obtain chromatograms of the chemical components in the test solution in step S1) and the mixed reference substance in step S2) under the same detection conditions, and the specific detection conditions are as follows:

[0114] Detector: VWD; Detector wavelength: 201 nm; Chromatographic column: GL Inertsil ODS-3 (250 mm*4.6 mm, 5 μm); Column temperature: 30°C; Mobile phase flow rate: 1.0 mL / min; Mobile phase A: acetonitrile, mobile phase B: 0.1% phosphoric acid solution; Injection volume: 10 μL; Mobile phase uses gradient elution, the specific elution gradient is:

[0115] 0-5min, mobile phase A is 12%; 5-14min, mobile phase A is 12%-20%; 14-21min, mobile phase A is 20%-22%; 21-29min, mobile phase A is 22%-23%; 29-39min, mobile phase A is 23%-28%; 39-48min, mobile phase A is 28%-42%; 48-68min, mobile phase A is 42%-60%; 68-70min, mobile phase A is 60%-12%; 70-72min, mobile phase A is 12%;

[0116] S4) according to the retention time of the mixed reference substance in the chromatogram and the retention time of the components corresponding to amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the test solution in the chromatogram of the test solution, and based on the detection conditions in step S3), the retention time of the active ingredients of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the Ergan Tuirening preparation is obtained, such as Fig.11 .

[0117] To further illustrate the present invention, the following experiments are used to provide a detailed description. In the present invention, the specific model and brand of the high performance liquid chromatograph are not limited, and those familiar to those skilled in the art are sufficient, such as Agilent or Elite.

[0118] Experimental example

[0119] 1. Positioning and ownership

[0120] Preparation of reference solution: Take an appropriate amount of Forsythiaside A reference substance, weigh it accurately, put it in a volumetric flask, add methanol to make a solution containing 0.2 mg per 1 mL, and the reference solution is obtained.

[0121] Preparation of single medicinal material solution: Weigh about 5 g of Artemisia annua, Forsythia suspensa, Platycodon grandiflorum, Isatis indigotica, Chrysanthemum, Bitter almond, Mint, and Licorice respectively, put them into a 250 mL round-bottom flask, add 100 mL of pure water, place it on an electric heating mantle, reflux extraction, and keep it at a slight boil for 1 hour, cool, filter, and take the filtrate to obtain the single medicinal material solution.

[0122] Preparation of single reference solution: guanosine, luteolin, forsythiaside B, uridine, scopoletin, 3,5-O-dicaffeoylquinic acid, (R, S)-goitrin, amygdalin, forsythiaside, chlorogenic acid, ferulic acid, glycyrrhetinic acid, kaempferol, liquiritin, forsythiaside A, platycoside D and ammonium glycyrrhizinate were taken respectively, and 100 vol% methanol was added to prepare 0.2 mg / mL guanosine reference substance, 0.2 mg / mL luteolin reference substance, 0.2 mg / mL forsythiaside B reference substance, 0.2 mg / mL uridine reference substance, 0.2 mg / mL scopoletin reference substance, 0.2 mg / mL 3,5- O-dicaffeoylquinic acid reference, (R,S)-goitrin reference at 0.2 mg / mL, amygdalin reference at 0.2 mg / mL, forsythiaside reference at 0.2 mg / mL, chlorogenic acid reference at 0.2 mg / mL, ferulic acid reference at 0.2 mg / mL, glycyrrhetinic acid reference at 0.2 mg / mL, kaempferol reference at 0.2 mg / mL, liquiritin reference at 0.2 mg / mL, forsythiaside A reference at 0.2 mg / mL, platycoside D reference at 0.2 mg / mL, and ammonium glycyrrhizinate reference at 0.2 mg / mL.

[0123] Preparation of the test solution: Take 2 mL of Ergan Tuirening preparation, add water to make up to 25 mL, filter through a 0.45 μm microporous filter membrane, and take the filtrate to obtain the test solution.

[0124] Using high performance liquid chromatography, according to Example The chromatographic conditions were as follows: blank solution (water), reference solution, single herbal medicine solution, single reference solution, and test solution were injected and tested. The experimental results are shown in Figure 8 to Figure 10 .

[0125] in, Fig.10 S1 to S19 are ammonium glycyrrhizinate, kaempferol, luteolin, platycoside D, forsythiaside, 3,5-O-dicaffeoylquinic acid, ferulic acid, scopoletin, liquiritin, forsythiaside A, forsythiaside B, chlorogenic acid, amygdalin, (R,S)-goitrin, glycyrrhizic acid, uridine, guanosine, test solution, and blank solution (water). Fig.11 Combination Figure 8 to Figure 10 It can be seen that the positioning results of the chemical components (chromatographic peaks) in the Ergan Tuirening preparation are shown in Table 3 - Chromatographic Peak Positioning Table.

[0126] Table 3

[0127] Peak Retention time (min) Compound Name Origin of the smell 1 5.803 —— Forsythia 2 12.085 —— —— 3 12.390 Amygdalin Bitter almonds 4 14.014 —— Forsythia / Platycodon 5 14.480 —— Licorice 6 17.527 —— Licorice 7 19.737 —— Forsythia 8 20.513 Forsythiaside A Forsythia 9 22.233 —— Licorice 10 23.109 Scopolamine chrysanthemum 11 23.607 —— chrysanthemum 12 24.235 —— Mint 13 26.383 —— Forsythia 14 31.694 —— chrysanthemum 15 39.403 Forsythiaside Forsythia 16 43.635 —— Mint / Chrysanthemum 17 47.316 Luteolin chrysanthemum 18 50.089 —— Forsythia 19 54.570 Ammonium glycyrrhizinate Licorice 20 55.960 —— Forsythia

[0128] According to the results of chromatographic peak positioning, the liquid fingerprint of Ergan Tuirening preparation obtained by this method can identify Forsythia suspensa, Licorice, Chrysanthemum, Apricot kernel and Menthus; it can locate reference substances such as amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate, and at the same time, the peak No. 3 corresponding to amygdalin in the test solution is determined, with a retention time of 12.390 min; the peak No. 8 corresponding to forsythiaside A is retained at a retention time of 20.513 min; the peak No. 10 corresponding to scopoletin is retained at a retention time of 23.109 min; the peak No. 15 corresponding to forsythiaside is retained at a retention time of 39.403 min; the peak No. 17 corresponding to luteolin is retained at a retention time of 47.316 min; the peak No. 19 corresponding to ammonium glycyrrhizinate is retained at a retention time of 54.570 min, and there is no interference in the blank.

[0129] 2. Exclusive inspection

[0130] Using high performance liquid chromatography, according to Example The blank solution (water) and the test solution were injected and tested under the chromatographic conditions. The experimental results are shown in Fig.12 .according to Fig.12 The results show that the solvent has no interference.

[0131] 3. Precision inspection

[0132] Take Ergan Tuirening preparation and prepare one test solution according to the method of "Test Solution Preparation". Use high performance liquid chromatography to Example The chromatographic conditions were set as follows, and six injections were made continuously to record the chromatogram. The sample similarity was evaluated using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System", and peak 8 (forsythiaside A) was used as the S peak to calculate the relative retention time and relative peak area of ​​the key common chromatographic peaks. The results are shown in Fig.13 , Table 4 (similarity calculation results), Table 5 (relative retention time calculation results) and Table 6 (relative peak area calculation results). Fig.13 Among them, S1~S6 are the test solutions, and R is the reference spectrum.

[0133] Table 4

[0134] S1 S2 S3 S4 S5 S6 S1 1.000 0.999 1.000 1.000 1.000 1.000 S2 0.999 1.000 0.999 1.000 1.000 1.000 S3 1.000 0.999 1.000 0.999 0.998 0.999 S4 1.000 1.000 0.999 1.000 0.999 0.999 S5 1.000 1.000 0.998 0.999 1.000 0.999 S6 1.000 1.000 0.999 0.999 0.999 1.000 R 1.000 1.000 0.999 1.000 0.999 0.998

[0135] Table 5

[0136] Peak S1 S2 S3 S4 S5 S6 RSD(%) 1 0.283 0.284 0.283 0.282 0.282 0.281 0.38 2 0.589 0.590 0.589 0.588 0.588 0.589 0.13 3 0.604 0.606 0.605 0.605 0.604 0.603 0.18 4 0.683 0.681 0.682 0.684 0.684 0.681 0.21 5 0.706 0.705 0.706 0.707 0.707 0.705 0.13 6 0.854 0.853 0.854 0.855 0.856 0.853 0.14 7 0.962 0.961 0.959 0.958 0.963 0.962 0.21 8 1.000 1.000 1.000 1.000 1.000 1.000 0.00 9 1.084 1.082 1.083 1.083 1.083 1.083 0.06 10 1.127 1.129 1.128 1.129 1.128 1.129 0.08 11 1.151 1.152 1.154 1.153 1.149 1.152 0.16 12 1.181 1.182 1.184 1.179 1.179 1.182 0.17 13 1.286 1.287 1.288 1.288 1.287 1.289 0.09 14 1.545 1.543 1.542 1.546 1.547 1.545 0.13 15 1.921 1.922 1.923 1.924 1.918 1.922 0.11 16 2.127 2.128 2.129 2.129 2.130 2.128 0.05 17 2.307 2.308 2.309 2.309 2.310 2.311 0.07 18 2.442 2.444 2.446 2.447 2.441 2.445 0.10 19 2.660 2.663 2.665 2.666 2.666 2.657 0.14 20 2.728 2.729 2.730 2.731 2.727 2.727 0.07

[0137] Table 6

[0138] Peak S1 S2 S3 S4 S5 S6 RSD(%) 1 0.399 0.398 0.399 0.398 0.399 0.399 0.13 2 0.0778 0.0777 0.0775 0.0777 0.0778 0.0775 0.18 3 0.0839 0.0842 0.0842 0.0840 0.0839 0.0840 0.16 4 0.101 0.102 0.100 0.100 0.101 0.100 0.81 5 0.0733 0.0732 0.0735 0.0733 0.0733 0.0735 0.17 6 0.0783 0.0785 0.0781 0.0784 0.0783 0.0784 0.17 7 0.376 0.373 0.379 0.376 0.379 0.379 0.65 8 1.000 1.000 1.000 1.000 1.000 1.000 0.00 9 0.184 0.185 0.186 0.185 0.186 0.186 0.44 10 0.173 0.176 0.176 0.176 0.176 0.176 0.70 11 0.0251 0.0252 0.0252 0.0252 0.0252 0.0252 0.16 12 0.586 0.585 0.589 0.586 0.585 0.589 0.32 13 0.187 0.188 0.185 0.187 0.188 0.186 0.63 14 0.201 0.204 0.202 0.202 0.204 0.202 0.60 15 0.453 0.456 0.454 0.454 0.454 0.454 0.22 16 0.0458 0.0457 0.0457 0.0457 0.0457 0.0457 0.09 17 0.188 0.189 0.186 0.189 0.188 0.186 0.73 18 0.0171 0.0170 0.0173 0.0171 0.0172 0.0172 0.61 19 0.0121 0.0122 0.0120 0.0121 0.0120 0.0119 0.87 20 0.0568 0.0569 0.0571 0.0568 0.0569 0.0571 0.24

[0139] According to the above determination results, the retention time and relative peak area of ​​the common peaks were examined, and the results showed that the retention time of each common peak was RSD≤1.0%; the relative peak area of ​​the common peak was RSD≤2.0%; the similarity results were not less than 0.99, which met the technical requirements of the fingerprint spectrum. This shows that the method has good precision.

[0140] 4. Repeatability test

[0141] Take the same batch of Ergan Tuirening preparation and prepare 6 test solutions according to the method of "Test Solution Preparation". Use high performance liquid chromatography, according to Example The chromatographic conditions were set, the samples were injected, and the chromatograms were recorded. The similarity was calculated using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System" (2012 Edition), and peak 8 (forsythiaside A) was used as the S peak. The relative retention time and relative peak area of ​​the key common chromatographic peaks were counted. The results are shown in Fig.14 , Table 7 (similarity calculation results), Table 8 (relative retention time calculation results) and Table 9 (relative peak area calculation results). Fig.14 S1-S6 are the test solutions; R is the reference spectrum.

[0142] Table 7

[0143]

[0144]

[0145] Table 8

[0146] Peak S1 S2 S3 S4 S5 S6 RSD(%) 1 0.283 0.284 0.282 0.283 0.283 0.281 0.37 2 0.589 0.590 0.588 0.589 0.589 0.589 0.11 3 0.604 0.606 0.604 0.605 0.604 0.603 0.18 4 0.683 0.681 0.684 0.683 0.682 0.681 0.18 5 0.706 0.705 0.704 0.707 0.706 0.705 0.15 6 0.854 0.853 0.852 0.855 0.852 0.853 0.14 7 0.962 0.961 0.961 0.958 0.959 0.962 0.18 8 1.000 1.000 1.000 1.000 1.000 1.000 0.00 9 1.084 1.082 1.086 1.084 1.083 1.083 0.13 10 1.127 1.129 1.128 1.130 1.128 1.129 0.10 11 1.151 1.152 1.149 1.153 1.154 1.152 0.16 12 1.181 1.182 1.184 1.179 1.184 1.182 0.17 13 1.286 1.287 1.288 1.288 1.288 1.289 0.09 14 1.545 1.543 1.547 1.546 1.542 1.545 0.13 15 1.921 1.922 1.918 1.924 1.923 1.922 0.11 16 2.127 2.128 2.130 2.129 2.129 2.127 0.06 17 2.307 2.308 2.310 2.310 2.309 2.311 0.07 18 2.442 2.444 2.440 2.444 2.446 2.445 0.09 19 2.660 2.663 2.665 2.666 2.665 2.657 0.14 20 2.728 2.729 2.725 2.731 2.730 2.727 0.08

[0147] Table 9

[0148]

[0149]

[0150] According to the above determination results, the retention time and relative peak area of ​​the common peaks were examined, and the results showed that the retention time of each common peak was RSD≤1.0%; the relative peak area of ​​the common peak was RSD≤2.0%; the similarity results were not less than 0.99, which met the technical requirements of the fingerprint spectrum. This shows that the method has good repeatability.

[0151] 5. Solution stability study

[0152] Take Ergan Tuirening preparation and prepare 1 test solution according to the method of "Test Solution Preparation", use high performance liquid chromatography, according to the chromatographic conditions of the embodiment, inject, and record the chromatograms at 0h, 4h, 8h, and 12h. Use the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System" (2012 Edition) to calculate its similarity, and use peak 8 (forsythiaside A) as the S peak to calculate the relative retention time and relative peak area of ​​the key common chromatographic peaks. The test results are shown in Fig.15 , Table 10 (similarity calculation results), Table 11 (relative retention time calculation results) and Table 12 (relative peak area calculation results). Fig.15 Wherein S1 is 0h; S2 is 4h; S3 is 8h; S4 is 12h; R is the reference spectrum.

[0153] Table 10

[0154] S1 S2 S3 S4 S1 1.000 1.000 0.999 0.999 S2 1.000 1.000 1.000 0.998 S3 0.999 1.000 1.000 0.998 S4 0.999 0.998 0.998 1.000 R 0.999 1.000 0.999 0.999

[0155] Table 11

[0156]

[0157]

[0158] Table 12

[0159] Peak S1 S2 S3 S4 RSD(%) 1 0.399 0.398 0.399 0.398 0.15 2 0.0778 0.0777 0.0775 0.0782 0.38 3 0.0839 0.0842 0.0842 0.0844 0.25 4 0.101 0.102 0.101 0.100 0.81 5 0.0733 0.0732 0.0736 0.0733 0.24 6 0.0783 0.0785 0.0781 0.0784 0.22 7 0.376 0.373 0.379 0.374 0.71 8 1.000 1.000 1.000 1.000 0.00 9 0.184 0.185 0.186 0.188 0.92 10 0.173 0.176 0.176 0.175 0.81 11 0.0251 0.0253 0.0252 0.0253 0.38 12 0.586 0.585 0.589 0.585 0.33 13 0.187 0.188 0.185 0.187 0.68 14 0.201 0.204 0.202 0.202 0.63 15 0.453 0.456 0.454 0.454 0.28 16 0.0458 0.0457 0.0459 0.0457 0.21 17 0.188 0.189 0.186 0.189 0.76 18 0.0171 0.0170 0.0173 0.0173 0.88 19 0.0121 0.0122 0.0120 0.0121 0.68 20 0.0568 0.0569 0.0566 0.0568 0.23

[0160] According to the above determination results, the retention time and relative peak area of ​​the common peaks were examined, and the results showed that the retention time of each common peak was RSD≤1.0%; the relative peak area of ​​the common peaks was RSD≤2.0%; the similarity results were not less than 0.99, which met the technical requirements of the fingerprint spectrum. This shows that the solution has good stability within 12 hours.

[0161] 6. Quality evaluation

[0162] Take 10 batches of Ergan Tuirening preparations and prepare 10 batches of test solutions according to the method of "Test Solution Preparation". Use high performance liquid chromatography to Example Chromatographic conditions were set, samples were injected, and chromatograms were recorded. The similarity was calculated using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System" (2012 Edition), and peak 8 (forsythiaside A) was used as the S peak to calculate the relative retention time and relative peak area of ​​the key common chromatographic peaks. The test results are shown in Fig.16 , Table 13 (similarity calculation results), Table 14 (relative retention time calculation results) and Table 15 (relative peak area calculation results). Fig.16 S1-S10 are 10 batches of test solutions, and R is the reference spectrum.

[0163] Table 13

[0164] S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S1 1.000 0.855 0.879 0.846 0.868 0.840 0.854 0.854 0.849 0.999 S2 0.855 1.000 0.979 0.998 0.988 0.998 0.995 0.995 0.999 0.852 S3 0.879 0.979 1.000 0.984 0.988 0.980 0.992 0.965 0.971 0.880 S4 0.846 0.998 0.984 1.000 0.989 0.999 0.999 0.989 0.996 0.846 S5 0.868 0.988 0.988 0.989 1.000 0.990 0.991 0.986 0.986 0.878 S6 0.840 0.998 0.980 0.999 0.990 1.000 0.997 0.993 0.997 0.840 S7 0.854 0.995 0.992 0.999 0.991 0.997 1.000 0.984 0.991 0.855 S8 0.854 0.995 0.965 0.989 0.986 0.993 0.984 1.000 0.997 0.854 S9 0.849 0.999 0.971 0.996 0.986 0.997 0.991 0.997 1.000 0.859 S10 1.000 0.855 0.879 0.846 0.868 0.840 0.854 0.854 0.849 1.000 R 0.947 0.975 0.978 0.972 0.978 0.970 0.975 0.971 0.972 0.948

[0165] Table 14

[0166]

[0167]

[0168] Table 15

[0169]

[0170] The above experimental results show that the similarity of fingerprint spectra of different batches of Ergan Tuirening preparations is greater than 0.9. The fingerprint spectrum detection method of Ergan Tuirening preparations provided by the present invention has good stability, high precision and good repeatability. Compared with the existing technology, it can comprehensively and objectively evaluate the quality of Ergan Tuirening preparations, which is of great significance for ensuring clinical safe use of drugs.

[0171] In summary, the present invention preferably uses the above-mentioned chromatographic column, which can well retain the sample components, the chromatographic peaks are more symmetrical, and the separation effect of each component and the adjacent chromatographic peaks is better. At the same time, the present invention uses the above-mentioned detector, which can accurately detect the main components in the test liquid, and the present invention uses the above-mentioned injection volume, flow rate and detection wavelength, which can make the chromatographic peaks of the fingerprint spectrum of the test liquid have better separation and response. The above-mentioned elution gradient used in the present invention is the optimal gradient. Under the above-mentioned gradient conditions, the number of chromatographic peaks is large, the separation of each chromatographic peak is good, and the detection result is more accurate and reliable.

[0172] The detection method provided by the present invention can obtain a good fingerprint of the Ergan Tuirening preparation, showing the chemical components in the Ergan Tuirening preparation. The present invention accurately measures 2 mL of the Ergan Tuirening preparation to make the detection result more precise and accurate; an aqueous solution is used as a solvent to prepare a test liquid, making the detection data more accurate and effective. This detection method solves the shortcomings of conventional quality inspections currently included in the pharmacopoeia, and provides an effective and controllable method for improving the quality control method of the Ergan Tuirening preparation.

[0173] The present invention also provides a method for establishing a fingerprint of chemical components in the Ergan Tuirening preparation, using the method for detecting the fingerprint of chemical components in the Ergan Tuirening preparation described in the above scheme. The fingerprint method of the present invention has high applicability, can accurately display the chemical components of the product, and can be used to control the stability of product quality.

[0174] The present invention also provides the application of the fingerprint spectrum obtained by the detection method described in the above scheme or the fingerprint spectrum obtained by the establishment method in the quality control of Ergan Tuirening preparation.

[0175] The above description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for detecting the fingerprint of chemical components in Ergan Tuirening preparation, characterized in that: include: The Ergan Tuirening preparation test solution is subjected to high performance liquid chromatography analysis to obtain a chromatogram of the test solution; The chromatographic conditions of the high performance liquid chromatography are: The chromatographic column is filled with octadecylsilane bonded silica gel; The flow rate of the mobile phase was 0.8-1.5 mL / min; the mobile phase was gradient elution; Mobile phase A was acetonitrile; mobile phase B was 0.1 vol% phosphoric acid solution; The column temperature was 30-40°C; the injection volume was 10-20 μL; and the detection wavelength was 201-210 nm.

2. The detection method according to claim 1, characterized in that: In volume percentage, the procedure of the gradient elution is: 0-5min, mobile phase A is 12%; 5-14 min, mobile phase A is 12%-20%; 14-21 min, mobile phase A is 20%-22%; 21-29 min, mobile phase A is 22%-23%; 29-39 min, mobile phase A is 23%-28%; 39-48 min, mobile phase A is 28%-42%; 48-68 min, mobile phase A is 42%-60%; 68-70 min, mobile phase A is 60%-12%; 70-72 min, mobile phase A 12%; or 0-15min, mobile phase A is 20%-28%; 15-23 min, mobile phase A is 28%-32%; 23-36 min, mobile phase A is 32%; 36-38 min, mobile phase A is 32%-34%; 38-40 min, mobile phase A is 34%-35%; 40-43 min, mobile phase A is 35%-36%; 43-48 min, mobile phase A is 36%-37%; 48-50 min, mobile phase A is 37%-39%; 50-60 min, mobile phase A is 39%-50%; 60-70 min, mobile phase A is 50%-80%; 70-71 min, mobile phase A is 80%-20%; 71-75 min, mobile phase A is 20%; or 0-5min, mobile phase A is 12%; 5-10 min, mobile phase A is 12%-18%; 10-21 min, mobile phase A is 18%-22%; 21-27 min, mobile phase A is 22%-23%; 27-40 min, mobile phase A is 23%-25%; 40-45 min, mobile phase A is 25%-40%; 45-46 min, mobile phase A 40%; 46-70 min, mobile phase A is 40%-54%; 70-73 min, mobile phase A is 54%-12%; 73-75min, mobile phase A is 12%; or 0-5min, mobile phase A is 12%; 5-10 min, mobile phase A is 12%-18%; 10-36 min, mobile phase A is 18%-23%; 36-47 min, mobile phase A is 23%-26%; 47-53 min, mobile phase A is 26%-40%; 53-55min, mobile phase A is 40%; 55-70min, mobile phase A is 40%-54%; 70-73 min, mobile phase A is 54%; 73-75min, mobile phase A is 54%-12%; 75-80 min, mobile phase A is 12%; or 0-5min, mobile phase A is 12%; 5-10 min, mobile phase A is 12%-18%; 10-45 min, mobile phase A is 18%-23%; 45-56 min, mobile phase A is 23%-26%; 56-65min, mobile phase A is 26%-40%; 65-66 min, mobile phase A is 40%; 66-78 min, mobile phase A is 40%-60%; 78-85 min, mobile phase A is 60%-12%; or 0-5min, mobile phase A is 12%; 5-10 min, mobile phase A is 12%-20%; 10-27 min, mobile phase A is 20%-23%; 27-40 min, mobile phase A is 23%-26%; 40-49 min, mobile phase A is 26%-40%; 49-70 min, mobile phase A is 40%-60%; 70-71 min, mobile phase A is 60%; 71-73 min, mobile phase A is 60%-12%; 73~75min, mobile phase A is 12%.

3. The detection method according to claim 1, characterized in that: The chromatographic column used was GL Inertsil ODS-3 column; the flow rate was 1.0 mL / min; the column temperature was 30°C; the injection volume was 10 μL; and the detection wavelength was 201 nm.

4. The detection method according to claim 1, characterized in that: The Ergan Tuirening preparation test solution is obtained by diluting the Ergan Tuirening preparation; The dilution solvent is water; the dilution multiple is 5 to 12.5 times.

5. The detection method according to claim 1, characterized in that: The detection method also includes preparing a mixed reference substance: Amygdalin, forsythiaside A, scopoletin, forsythin, luteolin and ammonium glycyrrhizinate were mixed with 100 vol% methanol to prepare a mixed reference substance; The mixed reference substance is subjected to high performance liquid chromatography analysis to obtain a chromatogram of the mixed reference substance.

6. The detection method according to claim 5, characterized in that: The mixed reference substance contains 0.2-0.3 mg / mL of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizinate respectively; According to the retention time of the mixed reference substance in the chromatogram and the retention time of the components corresponding to amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the test solution in the chromatogram of the test solution, the retention time of the active ingredients of amygdalin, forsythiaside A, scopoletin, forsythiaside, luteolin and ammonium glycyrrhizic acid in the Ergan Tuirening preparation is obtained.

7. The detection method according to claim 5 or 6, characterized in that: The retention time of peak No. 3 corresponding to the amygdalin is 12.390 min; the retention time of peak No. 8 corresponding to the forsythiaside A is 20.513 min; the retention time of peak No. 10 corresponding to the scopoletin is 23.109 min; the retention time of peak No. 15 corresponding to the forsythiaside is 39.403 min; the retention time of peak No. 17 corresponding to the luteolin is 47.316 min; the retention time of peak No. 19 corresponding to the ammonium glycyrrhizinate is 54.570 min.

8. The detection method according to any one of claims 1 to 7, characterized in that: The Ergan Tuirening preparation is made of Artemisia annua, Radix Isatidis, Chrysanthemum, Bitter Almond, Platycodon grandiflorum, Fructus Forsythiae, Mint and Licorice as active ingredients. The dosage form of the Ergan Tuirening preparation is granules, tablets, capsules, powders, pills, suspensions or oral liquid preparations.

9. A method for establishing a fingerprint of chemical components in Ergan Tuirening preparation, characterized in that: The fingerprint spectrum of the chemical components in the Ergan Tuirening preparation is obtained by using the detection method of the fingerprint spectrum of the chemical components in the Ergan Tuirening preparation as described in any one of claims 1 to 8.

10. Use of the fingerprint obtained by the detection method according to any one of claims 1 to 8 or the fingerprint of the chemical components in the Ergan Tuirening preparation obtained by the establishment method according to claim 9 in the quality control of the Ergan Tuirening preparation.